Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and four other institutions have developed a molecular test to identify the presence of brain tumors by measuring abnormal genetic material shed by tumors and circulating in cerebrospinal fluid (CSF).
Finnish study finds revised dementia guidelines did not reduce psychotropic use
A recent register-based study examined the impact of Finland’s revised clinical guidelines for the treatment of dementia, published in 2017, on the trend of users
September 25, 2023